Integrated Tissue and Blood miRNA Expression Profiles Identify Novel Biomarkers for Accurate Non-Invasive Diagnosis of Breast Cancer: Preliminary Results and Future Clinical Implications
Open Access
Abstract
We aimed to identify miRNAs that were closely related to breast cancer (BRCA). By integrating several methods including significance analysis of microarrays, fold change, Pearson’s correlation analysis, t test, and receiver operating characteristic analysis, we developed a decision-tree-based scoring algorithm, called Optimized Scoring Mechanism for Primary Synergy MicroRNAs (O-PSM). Five synergy miRNAs (hsa-miR-139-5p, hsa-miR-331-3p, hsa-miR-342-5p, hsa-miR-486-5p, and hsa-miR-654-3p) were identified using O-PSM, which were used to distinguish normal samples from pathological ones, and showed good results in blood data and in multiple sets of tissue data. These five miRNAs showed accurate categorization efficiency in BRCA typing and staging and had better categorization efficiency than experimentally verified miRNAs. In the Protein-Protein Interaction (PPI) network, the target genes of hsa-miR-342-5p have the most regulatory relationships, which regulate carcinogenesis proliferation and metastasis by regulating Glycosaminoglycan biosynthesis and the Rap1 signaling pathway. Moreover, hsa-miR-342-5p showed potential clinical application in survival analysis. We also used O-PSM to generate an R package uploaded on github (SuFei-lab/OPSM accessed on 22 October 2021). We believe that miRNAs included in O-PSM could have clinical implications for diagnosis, prognostic stratification and treatment of BRCA, proposing potential significant biomarkers that could be utilized to design personalized treatment plans in BRCA patients in the future.Keywords
Funding Information
- National Nature Science Foundation of China (Young Scientists Fund) (61801151, 2019M651298, LBH-Z18129, LBH-Z18187, LH2021F053, H2018014, BSDJS-20-07)
- China Postdoctoral Science Foundation (61801151, 2019M651298, LBH-Z18129, LBH-Z18187, LH2021F053, H2018014, BSDJS-20-07)
- Postdoctoral Foundation of Hei Long Jiang Province (61801151, 2019M651298, LBH-Z18129, LBH-Z18187, LH2021F053, H2018014, BSDJS-20-07)
- Natural Science Foundation of Heilongjiang Province (61801151, 2019M651298, LBH-Z18129, LBH-Z18187, LH2021F053, H2018014, BSDJS-20-07)
- Traditional Chinese Medicine (Tibetan Medicine) at the University of Tibetan Medicine (61801151, 2019M651298, LBH-Z18129, LBH-Z18187, LH2021F053, H2018014, BSDJS-20-07)
This publication has 88 references indexed in Scilit:
- Protein Kinase C Regulates Late Cell Cycle-Dependent Gene ExpressionMolecular and Cellular Biology, 2012
- Characterization of extracellular circulating microRNANucleic Acids Research, 2011
- Downregulation of miR-342 is associated with tamoxifen resistant breast tumorsMolecular Cancer, 2010
- Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancerNature Reviews Cancer, 2010
- NKX3.1 as a Marker of Prostatic Origin in Metastatic TumorsAmerican Journal of Surgical Pathology, 2010
- Effect of Screening and Adjuvant Therapy on Mortality from Breast CancerNew England Journal of Medicine, 2005
- Altered tumor vessel maturation and proliferation in placenta growth factor‐producing tumors: Potential relationship to post‐therapy tumor angiogenesis and recurrenceInternational Journal of Cancer, 2003
- The Epidermal Growth Factor Receptor Engages Receptor Interacting Protein and Nuclear Factor-κB (NF-κB)-inducing Kinase to Activate NF-κBJournal of Biological Chemistry, 2001
- Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase geneGenomics, 1992
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984